Braveheart, Attovia, Apnimed join gene therapy firm Scribe in July IPO rush
Seeking Alpha ·
A slew of biotechs have disclosed their IPO plans in July, with Attovia Therapeutics ( ATTO ), a biotech focused on immune-mediated diseases, and heart drug developer Braveheart ( BRVE ) announcing their intentions to go public this week.
DYAX Investor Sentiment
Bullish (Long) 40% · Bearish (Short) 60%
300 participants
Related News
- 금리 인상 우려 완화 속 미국 증시 선물 안정세…이란 긴장은 지속
- Warren Buffett Just Cut the Bill Gates Foundation From His Annual Donation for the First Time Since 2006. The Missing $4.5 Billion Goes to His Children's Charities.
- Why Phoenix Education Partners Dived by Almost 13% Today
- Can You Stomach The Plunge In Applied Optoelectronics Stock?
- 일라이릴리, 사이키델릭 제약사 AtaiBeckley 인수 협상 중 - 블룸버그
- The Real Risk Inside Marvell Stock